The Drugs Controller General of India (DCGI) has issued a new set of guidelines, focusing on safety, immunogenicity and efficacy parameters for pharma giants who are developing COVID-19 vaccines.
from NDTV News - Latest https://ift.tt/2EntxSq
Wednesday, 23 September 2020
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment